Comparison of serum IL-1β, sIL-2R, IL-6, and TNF-α levels with disease activity parameters in ankylosing spondylitis
- 1 April 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 26 (2), 211-215
- https://doi.org/10.1007/s10067-006-0283-5
Abstract
Ankylosing spondylitis (AS) is a chronic, inflammatory, rheumatological disease affecting primarily the sacroiliac joint and vertebral column, with an etiology that remains obscure. Cytokines are soluble proteins that have specific roles in inflammatory response, arranging the interaction between cells of the immune system both in natural and specific immune reactions. This study was planned to evaluate the relation between the level of cytokines and the clinical and laboratory findings of patients with AS compared to healthy subjects. In this study, we demonstrated increased serum levels of soluble interleukin-2 receptor (sIL-2R), Interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in patients with AS compared with healthy subjects. Only IL-1β levels were not increased in AS patients. We found a correlation between C-reactive protein and IL-6 levels and between erythrocyte sedimentation rate and sIL-2R, IL-6 and TNF-α levels. Only the sIL-2R level was correlated with Bath AS Metrology Index and Bath AS Functional Index. We suggest that sIL-2R, IL-6, and TNF-α may have a role in the pathogenesis of AS and that their serum levels can be used as disease activity parameters and tools for diagnosis.Keywords
This publication has 21 references indexed in Scilit:
- Open label trial of anakinra in active ankylosing spondylitis over 24 weeksAnnals Of The Rheumatic Diseases, 2005
- Tumour necrosis factor α as a therapeutic target for immune-mediated inflammatory diseasesCurrent Opinion in Biotechnology, 2004
- Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor blockers in ankylosing spondylitisAnnals Of The Rheumatic Diseases, 2004
- Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature reviewAnnals Of The Rheumatic Diseases, 2003
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- A relationship between TGF-beta 1 or IL-6 plasma levels and clinical features of spondyloarthropathiesRheumatology, 1997
- ANKYLOSING SPONDYLITIS: THE CORRELATION BETWEEN A NEW METROLOGY SCORE AND RADIOLOGYRheumatology, 1995
- SERUM CYTOKINES (IL-6, TNF-α, IL-1β AND IFN-γ) IN ANKYLOSING SPONDYLITIS: A CLOSE CORRELATION BETWEEN SERUM IL-6 AND DISEASE ACTIVITY AND SEVERITYRheumatology, 1994
- Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis.Annals Of The Rheumatic Diseases, 1994
- EVALUATION OF DIAGNOSTIC CRITERIA FOR ANKYLOSING SPONDYLITIS: A COMPARISON OF THE ROME, NEW YORK AND MODIFIED NEW YORK CRITERIA IN PATIENTS WITH A POSITIVE CLINICAL HISTORY SCREENING TEST FOR ANKYLOSING SPONDYLITISRheumatology, 1985